3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
12
Breast Neoplasms
9
Polycystic Ovary Syndrome
8
Obesity
7
Colorectal Neoplasms
7
Weight Loss
5
Colonic Neoplasms
5
Neoplasms
4
Endometrial Neoplasms
4
Prostatic Neoplasms
3
Multiple Endocrine Neoplasia Type 1
3
Recurrence
2
Pancreatic Neoplasms
2
Overweight
2
Ovarian Neoplasms
2
Malnutrition
2
Lymphoma, Follicular
2
Lymphoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Patient Compliance
1
Interventions
Metformin
7
Magnetic Resonance Spectroscopy
2
Inositol
2
Exercise
2
Ethinyl Estradiol
2
maltodextrin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Walking
1
Triptorelin Pamoate
1
Testosterone
1
Sugars
1
Spironolactone
1
Pyruvic Acid
1
Preoperative Exercise
1
Pioglitazone
1
Phlebotomy
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Leuprolide
1
Hepatectomy
1
Flutamide
1
Etanercept
1
Estrogens
1
Diet, Reducing
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet Therapy
1
Diet
1
Diathermy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metabolic Syndrome
×
Diet
×
Clear all
NCT03173807
2017-10-06
ProNEST
University of Pittsburgh
Phase NA
Withdrawn